Lilly announced Phase 3 topline results in adults with type 2 diabetes in March 2026, reporting reductions in A1C and body weight in that trial population
ConSynance Therapeuticss CSTI-500 CSTI-500 is a triple monoamine reuptake inhibitor (TRI) that modulates serotonin, dopamine, and norepinephrine by inhibiting their respective transporters (SERT, DAT, and NET)
Here are some key points about Mounjaros effectiveness: Higher Weight Loss : Clinical trials revealed that Mounjaro participants lost an average of 18.4% of their body weight compared to 14.9% with Wegovy and 15% with Ozempic, marking a significant new weight loss breakthrough
I constantly feel like my teeth are hairy, my boogers are like cement, my manicures don't last very long, and my vagina is drier than a popcorn fart
Watch for symptoms like muscle weakness, numbness, irregular heartbeat, or unusual bruisingthese require immediate medical attention